Sorry, you need to enable JavaScript to visit this website.

Study to Evaluate the Efficacy and Safety of PF-06651600 and PF-06700841 to Treat Moderate to Severe Alopecia Areata in Adults

A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety Profile of PF-06651600 and PF-06700841 in Subjects With Moderate to Severe Alopecia Areata With a Single-Blind Extension Period and a Cross-Over Open Label Extension Period

Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06651600 PF-06700841
ClinicalTrials.gov Identifier (NCT): NCT02974868
Protocol ID: B7931005
    Share
PrintDownload
Open Plain Language Summary Result: Click here